CN114364787A - 铜绿假单胞菌疫苗在呼吸系统疾病中的应用 - Google Patents

铜绿假单胞菌疫苗在呼吸系统疾病中的应用 Download PDF

Info

Publication number
CN114364787A
CN114364787A CN201980099562.7A CN201980099562A CN114364787A CN 114364787 A CN114364787 A CN 114364787A CN 201980099562 A CN201980099562 A CN 201980099562A CN 114364787 A CN114364787 A CN 114364787A
Authority
CN
China
Prior art keywords
pseudomonas aeruginosa
vaccine
infection
needle
cells
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN201980099562.7A
Other languages
English (en)
Other versions
CN114364787B (zh
Inventor
王震玲
魏于全
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sichuan University
Original Assignee
Sichuan University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CN201910777595.4A external-priority patent/CN112410212B/zh
Priority claimed from CN201910777473.5A external-priority patent/CN112402601B/zh
Priority claimed from CN201910777606.9A external-priority patent/CN112410240B/zh
Priority claimed from CN201910777479.2A external-priority patent/CN112410239B/zh
Priority claimed from CN201921369450.2U external-priority patent/CN211394490U/zh
Application filed by Sichuan University filed Critical Sichuan University
Publication of CN114364787A publication Critical patent/CN114364787A/zh
Application granted granted Critical
Publication of CN114364787B publication Critical patent/CN114364787B/zh
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/104—Pseudomonadales, e.g. Pseudomonas
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/10—Inactivation or decontamination of a medicinal preparation prior to administration to an animal or a person
    • A61K41/17—Inactivation or decontamination of a medicinal preparation prior to administration to an animal or a person by ultraviolet [UV] or infrared [IR] light, X-rays or gamma rays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6905—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a colloid or an emulsion
    • A61K47/6911—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a colloid or an emulsion the form being a liposome
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/21—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Pseudomonadaceae (F)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N13/00—Treatment of microorganisms or enzymes with electrical or wave energy, e.g. magnetism, sonic waves
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/74—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/521—Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55588—Adjuvants of undefined constitution
    • A61K2039/55594—Adjuvants of undefined constitution from bacteria
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/38—Pseudomonas
    • C12R2001/385—Pseudomonas aeruginosa

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Mycology (AREA)
  • Immunology (AREA)
  • Dermatology (AREA)
  • Communicable Diseases (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Oncology (AREA)
  • Virology (AREA)
  • Pulmonology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Dispersion Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

一种铜绿假单胞菌疫苗在制备防治呼吸系统疾病的药物中的应用。铜绿假单胞菌疫苗可以通过激活机体特应性免疫反应，能防治多药耐药铜绿假单胞菌导致的肺部感染，以及COPD合并铜绿假单胞菌感染。通过既定的免疫程序，降低接受免疫机体感染的细菌荷载量，可以预防肺部感染铜绿假单胞菌，在一定程度上规避了现有技术中采用抗生素不佳、难以根治、并且容易产生耐药性等技术问题。

Description

PCT国内申请，说明书已公开。

Claims (22)

  1. PCT国内申请，权利要求书已公开。
CN201980099562.7A 2019-08-22 2019-11-14 铜绿假单胞菌疫苗在呼吸系统疾病中的应用 Active CN114364787B (zh)

Applications Claiming Priority (11)

Application Number Priority Date Filing Date Title
CN201910777595.4A CN112410212B (zh) 2019-08-22 2019-08-22 一种细菌膜囊泡的生产系统和分离纯化系统及方法
CN2019107775954 2019-08-22
CN201910777473.5A CN112402601B (zh) 2019-08-22 2019-08-22 金黄色葡萄球菌膜囊泡及其制备方法与应用
CN201910777606.9A CN112410240B (zh) 2019-08-22 2019-08-22 铜绿假单胞菌膜囊泡及其制备方法与应用
CN201910777479.2A CN112410239B (zh) 2019-08-22 2019-08-22 细菌膜囊泡及其制备方法与应用
CN2019107774792 2019-08-22
CN2019107774735 2019-08-22
CN201921369450.2U CN211394490U (zh) 2019-08-22 2019-08-22 一种细菌膜囊泡的生产系统、分离系统和纯化系统
CN2019213694502 2019-08-22
CN2019107776069 2019-08-22
PCT/CN2019/118479 WO2021031409A1 (zh) 2019-08-22 2019-11-14 铜绿假单胞菌疫苗在呼吸系统疾病中的应用

Publications (2)

Publication Number Publication Date
CN114364787A true CN114364787A (zh) 2022-04-15
CN114364787B CN114364787B (zh) 2024-03-01

Family

ID=74659947

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201980099562.7A Active CN114364787B (zh) 2019-08-22 2019-11-14 铜绿假单胞菌疫苗在呼吸系统疾病中的应用

Country Status (3)

Country Link
US (3) US20220378902A1 (zh)
CN (1) CN114364787B (zh)
WO (3) WO2021031270A1 (zh)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2021031270A1 (zh) * 2019-08-22 2021-02-25 四川大学 细菌膜囊泡及其分离制备系统和方法

Citations (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1365950A (en) * 1970-10-20 1974-09-04 Eisai Co Ltd Pharmaceutical composition comprising a cell wall protein compo nent of pseudomonas aeruginosa
CN1112356A (zh) * 1993-06-07 1995-11-22 第一制糖株式会社 新型的减毒铜绿假单胞菌菌株
WO1997005899A2 (en) * 1995-08-04 1997-02-20 University Of Guelph Novel vaccines and pharmaceutical compositions using membrane vesicles of microorganisms, and methods for preparing same
WO2000033872A2 (en) * 1998-11-25 2000-06-15 Mcw Research Foundation, Inc. Method of and compositions for immunization with the pseudomonas v antigen
US20020028215A1 (en) * 1999-08-09 2002-03-07 Jagath L. Kadurugamuwa Novel vaccines and pharmaceutical compositions using membrane vesicles of microorganisms, and methods for preparing same
US20060134134A1 (en) * 2002-11-27 2006-06-22 Perez Martin Oliver G Method of obatining cochlear structures, vaccine compositions, adjuvants and interme- diates thereof
US20070281897A1 (en) * 2004-03-15 2007-12-06 Karaolis David K Method for stimulating the immune, inflammatory or neuroprotective response
CN102343086A (zh) * 2010-05-28 2012-02-08 四川大学 治疗或预防肿瘤的药物、肿瘤全细胞疫苗及其制备方法和用途
US20140004178A1 (en) * 2011-01-12 2014-01-02 The Administrators Of The Tulane Educational Fund Omv vaccine against burkholderia infections
CN104189898A (zh) * 2014-06-27 2014-12-10 四川大学 铜绿假单胞菌疫苗及其制备方法
CN104338128A (zh) * 2013-07-31 2015-02-11 普莱柯生物工程股份有限公司 一种疫苗组合物及其制备方法和应用
KR101632962B1 (ko) * 2015-07-29 2016-06-23 한국생명공학연구원 변형 외막소포체를 포함하는 항감염성 면역증강용 조성물
CN105713916A (zh) * 2016-02-15 2016-06-29 重庆医科大学附属第二医院 一种铜绿假单胞菌基因及其dna疫苗
CN105732818A (zh) * 2016-03-02 2016-07-06 中国人民解放军第三军医大学 一种铜绿假单胞菌重组蛋白pop及其制备方法和应用
CN105754978A (zh) * 2016-03-02 2016-07-13 中国人民解放军第三军医大学 一种铜绿假单胞菌重组蛋白Vac14及制备方法和应用
CN107137427A (zh) * 2017-06-22 2017-09-08 四川大学华西医院 铜绿假单胞菌的新用途
CN107397956A (zh) * 2017-08-08 2017-11-28 南开大学 一种铜绿假单胞菌外膜蛋白疫苗的制备方法及应用
CN108697778A (zh) * 2016-02-16 2018-10-23 哈佛学院院长等 病原体疫苗及其生产和使用方法
CN108743931A (zh) * 2018-05-02 2018-11-06 四川大学 抗结核病疫苗及其制备方法和用途
WO2019178487A2 (en) * 2018-03-15 2019-09-19 Evelo Biosciences, Inc. Compositions and methods for treating disease using klebsiella quasipneumoniae subsp. similipneumoniae
US20200138934A1 (en) * 2018-10-03 2020-05-07 The Administrators Of The Tulane Educational Fund Methods and compositions for preventing or ameliorating pseudomonas aeruginosa pulmonary infections
US20200281969A1 (en) * 2019-03-05 2020-09-10 Wonder Spray, LLC Inhibiting viral and bacterial activity using low concentration hypochlorous acid solutions
CN111701015A (zh) * 2020-07-19 2020-09-25 北京易思腾翻译服务有限公司 可防治新冠病毒感染等呼吸系统疾病和其他疾病的组合物
WO2021031409A1 (zh) * 2019-08-22 2021-02-25 四川大学 铜绿假单胞菌疫苗在呼吸系统疾病中的应用
CN112402601A (zh) * 2019-08-22 2021-02-26 四川大学 金黄色葡萄球菌膜囊泡及其制备方法与应用
CN112410239A (zh) * 2019-08-22 2021-02-26 四川大学 细菌膜囊泡及其制备方法与应用
CN112410240A (zh) * 2019-08-22 2021-02-26 四川大学 铜绿假单胞菌膜囊泡及其制备方法与应用
CN112646046A (zh) * 2021-01-09 2021-04-13 中国人民解放军陆军军医大学 用于预防铜绿假单胞菌感染的多表位融合蛋白及其编码基因、表达载体和应用
CN112755180A (zh) * 2020-12-30 2021-05-07 中国医学科学院医学生物学研究所 一种通用的细菌疫苗的制备方法和应用
WO2021195236A1 (en) * 2020-03-24 2021-09-30 Microbion Corporation Bismuth thiol compounds and compositions and methods of treating microbial co-infections
CN114364396A (zh) * 2019-08-22 2022-04-15 四川大学 铜绿假单胞菌疫苗在抗烧烫伤感染中的应用
CN115161377A (zh) * 2022-08-26 2022-10-11 四川大学华西医院 一种耐碳青霉烯铜绿假单胞菌的鉴定培养基及其制备方法和应用
CN115838648A (zh) * 2022-01-29 2023-03-24 成都威斯克生物医药有限公司 铜绿假单胞菌疫苗的工业化生产方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9918319D0 (en) * 1999-08-03 1999-10-06 Smithkline Beecham Biolog Vaccine composition
GB0220194D0 (en) * 2002-08-30 2002-10-09 Chiron Spa Improved vesicles
CN110872587A (zh) * 2007-05-22 2020-03-10 康乃尔研究基金会有限公司 蛋白质在细菌及其衍生小泡表面展示的组合物和方法及其用途
AU2013320313B2 (en) * 2012-09-18 2018-07-12 Glaxosmithkline Biologicals Sa Outer membrane vesicles
US20160120818A1 (en) * 2013-02-07 2016-05-05 Glaxosmithline Biological Sa Pharmaceutical compositions comprising vesicles
WO2015144691A1 (en) * 2014-03-26 2015-10-01 Glaxosmithkline Biologicals Sa Compositions for immunising against staphylococcus aureus
CN105647841A (zh) * 2014-09-04 2016-06-08 苏静 铜绿假单胞菌突变株构建方法及其应用
CN105709218A (zh) * 2016-03-18 2016-06-29 辽宁成大生物股份有限公司 一种奇异变形杆菌-金黄色葡萄球菌-铜绿假单胞菌吸附联合疫苗的制备方法
BR112019010227A2 (pt) * 2016-11-25 2019-10-08 Glaxosmithkline Biologicals Sa conjugado imunogênico, processo para preparação de conjugado imunogênico, composição imunogênica, vacina, e, uso de nomv
CN110028559B (zh) * 2019-04-15 2022-06-10 中国人民解放军陆军军医大学 一种铜绿假单胞菌疫苗重组蛋白及其编码基因和它们的应用

Patent Citations (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1365950A (en) * 1970-10-20 1974-09-04 Eisai Co Ltd Pharmaceutical composition comprising a cell wall protein compo nent of pseudomonas aeruginosa
CN1112356A (zh) * 1993-06-07 1995-11-22 第一制糖株式会社 新型的减毒铜绿假单胞菌菌株
WO1997005899A2 (en) * 1995-08-04 1997-02-20 University Of Guelph Novel vaccines and pharmaceutical compositions using membrane vesicles of microorganisms, and methods for preparing same
WO2000033872A2 (en) * 1998-11-25 2000-06-15 Mcw Research Foundation, Inc. Method of and compositions for immunization with the pseudomonas v antigen
US20020028215A1 (en) * 1999-08-09 2002-03-07 Jagath L. Kadurugamuwa Novel vaccines and pharmaceutical compositions using membrane vesicles of microorganisms, and methods for preparing same
US20060134134A1 (en) * 2002-11-27 2006-06-22 Perez Martin Oliver G Method of obatining cochlear structures, vaccine compositions, adjuvants and interme- diates thereof
US20070281897A1 (en) * 2004-03-15 2007-12-06 Karaolis David K Method for stimulating the immune, inflammatory or neuroprotective response
CN102343086A (zh) * 2010-05-28 2012-02-08 四川大学 治疗或预防肿瘤的药物、肿瘤全细胞疫苗及其制备方法和用途
US20140004178A1 (en) * 2011-01-12 2014-01-02 The Administrators Of The Tulane Educational Fund Omv vaccine against burkholderia infections
CN104338128A (zh) * 2013-07-31 2015-02-11 普莱柯生物工程股份有限公司 一种疫苗组合物及其制备方法和应用
CN104189898A (zh) * 2014-06-27 2014-12-10 四川大学 铜绿假单胞菌疫苗及其制备方法
KR101632962B1 (ko) * 2015-07-29 2016-06-23 한국생명공학연구원 변형 외막소포체를 포함하는 항감염성 면역증강용 조성물
CN105713916A (zh) * 2016-02-15 2016-06-29 重庆医科大学附属第二医院 一种铜绿假单胞菌基因及其dna疫苗
CN108697778A (zh) * 2016-02-16 2018-10-23 哈佛学院院长等 病原体疫苗及其生产和使用方法
CN105732818A (zh) * 2016-03-02 2016-07-06 中国人民解放军第三军医大学 一种铜绿假单胞菌重组蛋白pop及其制备方法和应用
CN105754978A (zh) * 2016-03-02 2016-07-13 中国人民解放军第三军医大学 一种铜绿假单胞菌重组蛋白Vac14及制备方法和应用
CN107137427A (zh) * 2017-06-22 2017-09-08 四川大学华西医院 铜绿假单胞菌的新用途
CN107397956A (zh) * 2017-08-08 2017-11-28 南开大学 一种铜绿假单胞菌外膜蛋白疫苗的制备方法及应用
WO2019178487A2 (en) * 2018-03-15 2019-09-19 Evelo Biosciences, Inc. Compositions and methods for treating disease using klebsiella quasipneumoniae subsp. similipneumoniae
CN108743931A (zh) * 2018-05-02 2018-11-06 四川大学 抗结核病疫苗及其制备方法和用途
US20200138934A1 (en) * 2018-10-03 2020-05-07 The Administrators Of The Tulane Educational Fund Methods and compositions for preventing or ameliorating pseudomonas aeruginosa pulmonary infections
US20200281969A1 (en) * 2019-03-05 2020-09-10 Wonder Spray, LLC Inhibiting viral and bacterial activity using low concentration hypochlorous acid solutions
CN114364396A (zh) * 2019-08-22 2022-04-15 四川大学 铜绿假单胞菌疫苗在抗烧烫伤感染中的应用
WO2021031409A1 (zh) * 2019-08-22 2021-02-25 四川大学 铜绿假单胞菌疫苗在呼吸系统疾病中的应用
CN112402601A (zh) * 2019-08-22 2021-02-26 四川大学 金黄色葡萄球菌膜囊泡及其制备方法与应用
CN112410239A (zh) * 2019-08-22 2021-02-26 四川大学 细菌膜囊泡及其制备方法与应用
CN112410240A (zh) * 2019-08-22 2021-02-26 四川大学 铜绿假单胞菌膜囊泡及其制备方法与应用
US20220378901A1 (en) * 2019-08-22 2022-12-01 Sichuan University Application of pseudomonas aeruginosa vaccine in respiratory disease
WO2021195236A1 (en) * 2020-03-24 2021-09-30 Microbion Corporation Bismuth thiol compounds and compositions and methods of treating microbial co-infections
CN111701015A (zh) * 2020-07-19 2020-09-25 北京易思腾翻译服务有限公司 可防治新冠病毒感染等呼吸系统疾病和其他疾病的组合物
CN112755180A (zh) * 2020-12-30 2021-05-07 中国医学科学院医学生物学研究所 一种通用的细菌疫苗的制备方法和应用
CN112646046A (zh) * 2021-01-09 2021-04-13 中国人民解放军陆军军医大学 用于预防铜绿假单胞菌感染的多表位融合蛋白及其编码基因、表达载体和应用
CN115838648A (zh) * 2022-01-29 2023-03-24 成都威斯克生物医药有限公司 铜绿假单胞菌疫苗的工业化生产方法
WO2023142201A1 (zh) * 2022-01-29 2023-08-03 成都威斯克生物医药有限公司 铜绿假单胞菌疫苗的工业化生产方法
CN115161377A (zh) * 2022-08-26 2022-10-11 四川大学华西医院 一种耐碳青霉烯铜绿假单胞菌的鉴定培养基及其制备方法和应用

Non-Patent Citations (8)

* Cited by examiner, † Cited by third party
Title
JULIANA P. 等: "Increased production of outer membrane vesicles by cultured freshwater bacteria in response to ultraviolet radiation", MICROBIOLOGICAL RESEARCH, vol. 2017, pages 304 - 305 *
XIAOLI ZHANG等: "Immunization with Pseudomonas aeruginosa outer membrane vesicles stimulates protective immunity in mice" *
XIAOLI ZHANG等: "Immunization with Pseudomonas aeruginosa outer membrane vesicles stimulates protective immunity in mice", VACCINE, vol. 36, pages 1048 *
丁烨;戴璐;俞娟;: "抗铜绿假单胞菌感染治疗方法研究进展", no. 06, pages 955 - 960 *
何爱琳;李文桂;: "铜绿假单胞菌PcrV疫苗研制现状", no. 06, pages 737 - 741 *
吴晓烽;秦竹;史海健;余刚;董瑶;: "抗菌药物递送系统的研究进展", 江苏农业科学, no. 10, 24 May 2018 (2018-05-24), pages 13 - 17 *
肖非;曹二龙;卿蕊;胡智;: "IL-2与IL-33佐剂增强铜绿假单胞菌外膜囊泡的免疫保护效果", no. 16, pages 1946 - 1950 *
高清华;万莹;: "铜绿假单胞菌临床感染特征及控制对策的研究进展", no. 02, pages 79 - 81 *

Also Published As

Publication number Publication date
WO2021032179A1 (zh) 2021-02-25
US20220370588A1 (en) 2022-11-24
WO2021031409A1 (zh) 2021-02-25
US20220378901A1 (en) 2022-12-01
CN114364787B (zh) 2024-03-01
WO2021031270A1 (zh) 2021-02-25
US20220378902A1 (en) 2022-12-01

Similar Documents

Publication Publication Date Title
US8518416B2 (en) Compositions and methods for treatment of microbial infections
AU699487B2 (en) Methods of treating and detecting cancer using viruses
CN112755180B (zh) 一种通用的细菌疫苗的制备方法和应用
WO2010139193A1 (zh) 手足口病疫苗及其制备方法和应用
CN112843228B (zh) 一种兔巴氏杆菌病二价灭活疫苗及其制备方法
CN114340609B (zh) 产生安全量的一氧化氮的药物组合物及其用途
Luo et al. Diagnosis and treatment of pulmonary mucormycosis: a case report
US20180161414A1 (en) Vaccine comprising lactobacillus strains for treating prostate inflammation and benign prostate hyperplasias
CN113521101A (zh) 干细胞来源的外泌体在制备治疗慢性阻塞性肺疾病药物中的应用
CN110643541A (zh) 一株可调节过敏性哮喘Th2/Th1平衡的干酪乳杆菌及其应用
US20220267419A1 (en) Human Immunoglobulin Against Methicillin-Resistant Staphylococcus Aureus, Preparation Method Therefor, And Use Thereof
CN114364787B (zh) 铜绿假单胞菌疫苗在呼吸系统疾病中的应用
CN115518079A (zh) 一种益生菌及其外膜囊泡在制备防治支气管哮喘制剂中的应用
CN114377127B (zh) 一种三联卵黄抗体制剂及其制备方法和应用
CN114364396B (zh) 铜绿假单胞菌疫苗在抗烧烫伤感染中的应用
US20090162324A1 (en) Use of Whole Cell Actinomycetales Bacteria to Treat Stress-Induced Pulmonary Haemorrhage
CN111826296B (zh) 人葡萄球菌及其培养方法和应用
Kanareykina et al. Proteus dysbioses in patients with ulcerative colitis
RU2695366C1 (ru) Способ лечения бронхолегочных заболеваний
Ryu et al. Acute respiratory distress syndrome induced by adenovirus in an otherwise healthy woman
CN111214495B (zh) 注射用母牛分枝杆菌在制备用于防治呼吸系rsv感染的药物中的应用
CN112386682B (zh) 纤连蛋白在制备治疗新型冠状病毒肺炎药物中的应用
US12029767B2 (en) Treating or preventing respiratory infection
US20240226156A1 (en) Anti-fibrotic tissue resident memory t cells and uses thereof
CN102764429A (zh) 一种用于上调动物体内调节性t细胞的组合物及其用途

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant